• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Suda Kenichi  須田 健一

ORCIDConnect your ORCID iD *help
… Alternative Names

SUDA Kenichi  須田 健一

Less
Researcher Number 30631593
Other IDs
Affiliation (Current) 2025: 近畿大学, 医学部, 講師
Affiliation (based on the past Project Information) *help 2018 – 2024: 近畿大学, 医学部, 講師
2013 – 2015: 近畿大学, 医学部, 助教
2013: 九州大学, 大学病院, その他
2012: 九州大学, 大学病院, 臨床助教
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics / Thoracic surgery
Except Principal Investigator
Basic Section 55040:Respiratory surgery-related / Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields / Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords
Principal Investigator
獲得耐性 / 分子標的治療薬 / EGFR遺伝子変異 / 分子標的治療 / 肺癌 / 第4世代 / チロシンキナーゼ阻害剤 / EGFR変異肺がん / EGFR変異検査 / CD44 … More / 上皮間葉転換 / Drug tolerance / tumor heterogeneity / 肺腺がん / 免疫チェックポイント / 薬剤感受性 / バイオマーカー / heterogeniety / 個別化治療 / EGFR変異 / 耐性 / 分子標的薬 / 薬剤耐性 / 癌 … More
Except Principal Investigator
肺がん / 薬剤耐性 / 肺癌 / 腫瘍微小環境 / マイクロバイオーム / 早期肺腺がん / 血小板 / 標的薬 / 変異 / KRAS / HER異常 / 胃がん / 乳がん / HER2異常 / ERBB2 / HER2 Less
  • Research Projects

    (9 results)
  • Research Products

    (99 results)
  • Co-Researchers

    (14 People)
  •  Evaluation of minimal residual disease in postoperative lung cancer using platelet RNA influenced by the tumor environment.

    • Principal Investigator
      坂井 和子
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Kindai University
  •  Basic Research for Elucidating and Overcoming the Mechanisms of Progression of Early-Stage Lung Adenocarcinoma

    • Principal Investigator
      宗 淳一
    • Project Period (FY)
      2023 – 2026
    • Research Category
      Fund for the Promotion of Joint International Research (International Collaborative Research)
    • Review Section
      Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields
    • Research Institution
      Kindai University
  •  EGFR変異肺癌に対する第4世代EGFR-TKIの有用性とその獲得耐性機序の解明Principal Investigator

    • Principal Investigator
      須田 健一
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Kindai University
  •  Targeted therapy for the patient with KRAS mutant lung cancer

    • Principal Investigator
      宗 淳一
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55040:Respiratory surgery-related
    • Research Institution
      Kindai University
  •  Development of a new treatment strategy for HER2-alterated lung cancer

    • Principal Investigator
      Soh Junichi
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55040:Respiratory surgery-related
    • Research Institution
      Kindai University
  •  Exploration of predictive molecular biomarkers for acquired resistance mechanisms to EGFR tyrosine kinase inhibitorsPrincipal Investigator

    • Principal Investigator
      Suda Kenichi
    • Project Period (FY)
      2018 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Kindai University
  •  肺癌における薬剤耐性因子のheterogenietyとその克服Principal Investigator

    • Principal Investigator
      須田 健一
    • Project Period (FY)
      2015
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Kinki University
  •  Analysis of acquired resistance mechanisms to next-generation kinase inhibitors in lung cancers with EGFR mutation.Principal Investigator

    • Principal Investigator
      SUDA Kenichi
    • Project Period (FY)
      2013 – 2014
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Kinki University
  •  EGFR変異肺癌のキナーゼ阻害剤耐性機序の解明とその克服に向けた新規治療への展開Principal Investigator

    • Principal Investigator
      須田 健一
    • Project Period (FY)
      2012 – 2013
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Research Field
      Thoracic surgery
    • Research Institution
      Kyushu University

All 2024 2023 2022 2021 2020 2019 2018 2015 2014 2013 2012 Other

All Journal Article Presentation Book

  • [Book] PTEN - Structure, Mechanisms-of-Action, Role in Cell Signaling and Regulation2013

    • Author(s)
      Suda K, et al.
    • Total Pages
      265
    • Publisher
      NOVA BIOMEDICAL
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Journal Article] Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion2024

    • Author(s)
      Hamada Akira、Suda Kenichi、Nishino Masaya、Obata Keiko、Oiki Hana、Fukami Tomoyo、Fukuda Shota、Fujino Toshio、Ohara Shuta、Koga Takamasa、Chiba Masato、Shimoji Masaki、Ito Masaoki、Takemoto Toshiki、Soh Junichi、Tsutani Yasuhiro、Mitsudomi Tetsuya
    • Journal Title

      Journal of Thoracic Oncology

      Volume: 19 Issue: 1 Pages: 71-79

    • DOI

      10.1016/j.jtho.2023.08.029

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23K15569, KAKENHI-PROJECT-22K07291, KAKENHI-PROJECT-20K17763
  • [Journal Article] Recent Advances in Perioperative Immunotherapies in Lung Cancer2023

    • Author(s)
      Fukuda S, Suda K, Hamada A, Tsutani Y.
    • Journal Title

      Biomolecules

      Volume: 13 Issue: 9 Pages: 1377-1377

    • DOI

      10.3390/biom13091377

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Journal Article] Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective study2023

    • Author(s)
      Hamada A, Kitajima K, Suda K, Koga T, Soh J, Kaida H, Ito K, Sekine T, Takegahara K, Daisaki H, Hashimoto M, Yoshida Y, Kabasawa T, Yamasaki T, Hirota S, Usuda J, Ishii K, Mitsudomi T.
    • Journal Title

      JTCVS Open

      Volume: 14 Pages: 502-22

    • DOI

      10.1016/j.xjon.2023.02.004

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K07291, KAKENHI-PROJECT-20K17763
  • [Journal Article] Performance of Ultra-Rapid Idylla EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening2023

    • Author(s)
      Suda K, Sakai K, Ohira T, Chikugo T, Satou T, Matsubayashi J, Nagao T, Ikeda N, Tsutani Y, Mitsudomi T, Nishio K.
    • Journal Title

      Cancers

      Volume: 15 Issue: 9 Pages: 2648-2648

    • DOI

      10.3390/cancers15092648

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K07291, KAKENHI-PROJECT-23K06432
  • [Journal Article] Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancer.2022

    • Author(s)
      Koga T, Suda K, Mitsudomi T.
    • Journal Title

      Cancer Science

      Volume: 113 Issue: 3 Pages: 815-827

    • DOI

      10.1111/cas.15263

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer.2022

    • Author(s)
      Suda K, Ohara S, Fujino T, Hamada A, M Chiba, Shimoji M, Takemoto T, Soh J, Mitsudomi T.
    • Journal Title

      Clinical Lung Cancer

      Volume: 23 Issue: 1 Pages: e60-e68

    • DOI

      10.1016/j.cllc.2021.10.003

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] 肺癌の分子標的治療の現状と展望.2022

    • Author(s)
      須田健一, 光冨徹哉.
    • Journal Title

      胸部外科

      Volume: 75 Pages: 53-66

    • NAID

      40022786239

    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers-Applications and Limitations2021

    • Author(s)
      Ohara S, Suda K, Mitsudomi T
    • Journal Title

      Cells

      Volume: 10 Issue: 2 Pages: 354-354

    • DOI

      10.3390/cells10020354

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-20K17764
  • [Journal Article] Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges.2021

    • Author(s)
      Fujino T, Suda K, Mitsudomi T.
    • Journal Title

      Lung Cancer: Targets and Therapy

      Volume: 12 Pages: 35-50

    • DOI

      10.2147/lctt.s269307

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K16813, KAKENHI-PROJECT-21K15580
  • [Journal Article] KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In_Vitro Experiments.2021

    • Author(s)
      Koga T, Suda K, Fujino T, Ohara S, Hamada A, Nishino M, Chiba M, Shimoji M, Takemoto T, Arita R, Gmachl M, Hofmann MH, Soh J, Mitsudomi T.
    • Journal Title

      Journal of Thoracic Oncology

      Volume: 16 Issue: 8 Pages: 1321-1332

    • DOI

      10.1016/j.jtho.2021.04.015

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations.2021

    • Author(s)
      Suda K, Mitsudomi T.
    • Journal Title

      Cells

      Volume: 10 Issue: 7 Pages: 1590-1590

    • DOI

      10.3390/cells10071590

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study.2021

    • Author(s)
      Koga T, Suda K, Nishino M, Fujino T, Ohara S, Hamada A, Soh J, Tirunagaru V, Vellanki A, Doebele RC, Mitsudomi T.
    • Journal Title

      Translational Lung Cancer Research

      Volume: 10 Issue: 8 Pages: 3659-3670

    • DOI

      10.21037/tlcr-21-216

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K09285
  • [Journal Article] In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial.2021

    • Author(s)
      Hamada A, Suda K, Koga T, Fujino T, Nishino M, Ohara S, Chiba M, Shimoji M, Takemoto T, Soh J, Uchida T, Mitsudomi T.
    • Journal Title

      Lung Cancer

      Volume: 162 Pages: 79-85

    • DOI

      10.1016/j.lungcan.2021.10.014

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K09285, KAKENHI-PROJECT-20K17763
  • [Journal Article] Inter- and Intratumor Heterogeneity of EGFR Compound Mutations in Non-Small Cell Lung Cancers: Analysis of Five Cases2021

    • Author(s)
      Suda K, Sakai K, Obata K, Ohara S, Fujino T, Koga T, Hamada A, Soh J, Nishio K, Mitsudomi T
    • Journal Title

      Clinical Lung Cancer

      Volume: 22 Issue: 2 Pages: e141-e145

    • DOI

      10.1016/j.cllc.2020.09.009

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer2021

    • Author(s)
      Ohara S, Suda K, Fujino T, Hamada A, Koga T, Nishino M, Chiba M, Shimoji M, Takemoto T, Soh J, Mitsudomi T
    • Journal Title

      Lung Cancer

      Volume: 154 Pages: 84-91

    • DOI

      10.1016/j.lungcan.2021.02.017

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K16785, KAKENHI-PROJECT-20K17764
  • [Journal Article] Recent Advances in Cancer Immunotherapy.2021

    • Author(s)
      Suda K.
    • Journal Title

      Biomolecules

      Volume: 11 Issue: 2 Pages: 335-335

    • DOI

      10.3390/biom11020335

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] 早期肺がんへのLiquid biopsyの応用 -再発予測としてのMinimal Residual Disease検出の意義-.2021

    • Author(s)
      小原秀太, 須田健一, 光冨徹哉.
    • Journal Title

      近畿大学医学雑誌

      Volume: 46 Pages: 73-78

    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer2020

    • Author(s)
      Ohara S, Suda K, Tomizawa K, Takemoto T, Fujino T, Hamada A, Koga T, Nishino M, Chiba M, Sato K, Shimoji M, Soh J, Mitsudomi T
    • Journal Title

      Surgery Today

      Volume: 50 Issue: 11 Pages: 1427-1433

    • DOI

      10.1007/s00595-020-02019-1

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-20K17764
  • [Journal Article] Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer2020

    • Author(s)
      Suda K, Murakami I, Obata K, Sakai K, Fujino T, Koga T, Ohara S, Hamada A, Soh J, Nishio K, Mitsudomi T
    • Journal Title

      Lung Cancer

      Volume: 148 Pages: 100-104

    • DOI

      10.1016/j.lungcan.2020.08.010

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy2020

    • Author(s)
      Suda K, Mitsudomi T
    • Journal Title

      Translational Lung Cancer Research

      Volume: 9 Issue: 6 Pages: 2618-2628

    • DOI

      10.21037/tlcr-20-186

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer2020

    • Author(s)
      Fujino T, Suda K, Mitsudomi T
    • Journal Title

      Expert Opinion on Emerging Drugs

      Volume: 25 Issue: 3 Pages: 229-249

    • DOI

      10.1080/14728214.2020.1791821

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K16813
  • [Journal Article] Comparison of PD-L1 Expression Status Between Pure-Solid Versus Part-Solid Lung Adenocarcinomas.2019

    • Author(s)
      Suda K, Shimoji M, Shimizu S, Sato K, Chiba M, Tomizawa K, Takemoto T, Soh J, Mitsudomi T.
    • Journal Title

      Biomolecules

      Volume: 9 Issue: 9 Pages: 456-456

    • DOI

      10.3390/biom9090456

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] The ABCs of Preventing Hyperprogressive Disease After Immunotherapy: Awareness, Biomarkers, and Combination.2019

    • Author(s)
      Suda K.
    • Journal Title

      Journal of Thoracic Disease

      Volume: 11 (Suppl 3) Issue: S3 Pages: S347-S351

    • DOI

      10.21037/jtd.2018.12.112

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] For a better adjuvant strategy for resected lung cancer-lessons from treatment failure patterns of the ADJUVANT trial (CTONG 1104).2019

    • Author(s)
      Suda K.
    • Journal Title

      Translational Lung Cancer Research

      Volume: 8 (Suppl 4) Issue: S4 Pages: S395-S399

    • DOI

      10.21037/tlcr.2019.08.24

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro2019

    • Author(s)
      Fujino T, Kobayashi Y, Suda K, Koga T, Nishino M, Ohara S, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T.
    • Journal Title

      Journal of Thoracic Oncology

      Volume: 14 Issue: 10 Pages: 1753-1765

    • DOI

      10.1016/j.jtho.2019.06.023

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-16H06276
  • [Journal Article] Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro.2018

    • Author(s)
      Nishino M, Suda K, Kobayashi Y, Ohara S, Fujino T, Koga T, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T
    • Journal Title

      Lung Cancer

      Volume: 126 Pages: 149-155

    • DOI

      10.1016/j.lungcan.2018.10.026

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.2018

    • Author(s)
      Suda K, Murakami I, Yu H, Kim J, Tan AC, Mizuuchi H, Rozeboom L, Ellison K, Rivard CJ, Mitsudomi T, Hirsch FR
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: 10 Pages: 2257-2265

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naive Lesions.2018

    • Author(s)
      Suda K, Kim J, Murakami I, Rozeboom L, Shimoji M, Shimizu S, Rivard CJ, Mitsudomi T, Tan AC, Hirsch FR
    • Journal Title

      Journal of Thoracic Oncology

      Volume: 10 Issue: 10 Pages: 1496-1507

    • DOI

      10.1016/j.jtho.2018.05.039

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Intraoperative molecular imaging-a bright navigator for thoracic surgeons in the era of limited resection.2018

    • Author(s)
      Suda K
    • Journal Title

      Translational Lung Cancer Research

      Volume: Suppl 3. Issue: S3 Pages: S232-S235

    • DOI

      10.21037/tlcr.2018.08.13

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Journal Article] Racial differences in lung cancer genetics.2015

    • Author(s)
      Kenichi Suda, and Tetsuya Mitsudomi
    • Journal Title

      Journal of Thoracic Oncology

      Volume: 10 Issue: 2 Pages: 230-1

    • DOI

      10.1097/jto.0000000000000439

    • Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Journal Article] Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity2015

    • Author(s)
      Suda K., Mitsudomi T.
    • Journal Title

      Arch Toxicol

      Volume: 89 Issue: 8 Pages: 1227-40

    • DOI

      10.1007/s00204-015-1524-7

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-15K18450
  • [Journal Article] Recent evidence, advances, and current practices in surgical treatment of lung cancer2014

    • Author(s)
      Kenichi Suda, Katsuaki Sato, Hiroshi Mizuuchi, Yoshihisa Kobayashi, Masaki Shimoji, Kenji Tomizawa, Toshiki Takemoto, Takuya Iwasaki, Masahiro Sakaguchi, Tetsuya Mitsudomi
    • Journal Title

      Respiratory Investigation

      Volume: 52 Issue: 6 Pages: 322-9

    • DOI

      10.1016/j.resinv.2014.06.003

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Journal Article] CRKL amplification is rare as a mechanism for acquired resistance tokinase inhibitors in lung cancers with epidermal growth factorreceptor mutation2014

    • Author(s)
      Kenichi Suda, Hiroshi Mizuuchi, Isao Murakami, Hidetaka Uramoto,Fumihiro Tanaka, Katsuaki Sato, Toshiki Takemoto, Takuya Iwasaki,Yoshitaka Sekido, Yasushi Yatabe, Tetsuya Mitsudomi
    • Journal Title

      Lung Cancer

      Volume: 85 Pages: 147-51

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Journal Article] Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma2014

    • Author(s)
      Kenichi Suda, Katsuaki Sato, Shigeki Shimizu, Kenji Tomizawa, Toshiki Takemoto, Takuya Iwasaki, Masahiro Sakaguchi, and Tetsuya Mitsudomi
    • Journal Title

      BioMed Research International

      Volume: 2014 Pages: 1-6

    • DOI

      10.1155/2014/645681

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Journal Article] The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor.2014

    • Author(s)
      Suda K, Mizuuchi H, Sato K, Takemoto T, Iwasaki T, Mitsudomi T.
    • Journal Title

      Int. J. Cancer

      Volume: in press Issue: 4 Pages: 1002-6

    • DOI

      10.1002/ijc.28737

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Journal Article] Unintentional Weakness of Cancers: The MEK–ERK Pathway as a Double-Edged Sword.2013

    • Author(s)
      Suda K and Mitsudomi T.
    • Journal Title

      Molecular Cancer Research

      Volume: 11 Issue: 10 Pages: 1125-8

    • DOI

      10.1158/1541-7786.mcr-13-0228

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Journal Article] Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond.2013

    • Author(s)
      Suda K and Mitsudomi T.
    • Journal Title

      Lung Cancer: Targets and THerapy

      Volume: 4 Pages: 43-53

    • DOI

      10.2147/lctt.s49603

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Journal Article] 肺癌UPDATE 肺癌の分子生物学 肺癌のoncogenic driver mutations2012

    • Author(s)
      須田 健一、 他
    • Journal Title

      医学のあゆみ

      Volume: 240 Pages: 1059-65

    • Data Source
      KAKENHI-PROJECT-24890159
  • [Journal Article] EGFR tyrosine kinase inhibitors prolong overall survival in EGFR mutated non-small-cell lung cancer patients with postsurgical recurrence2012

    • Author(s)
      Suda K., et al.
    • Journal Title

      Journal of Cancer Research Updates

      Volume: 1 Pages: 102-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24890159
  • [Journal Article] 抗がん剤治療の最前線:分子標的薬剤の使用による進歩(後篇)2012

    • Author(s)
      須田 健一、 他
    • Journal Title

      最新医学

      Volume: 67 Pages: 2104-15

    • Data Source
      KAKENHI-PROJECT-24890159
  • [Journal Article] Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.2012

    • Author(s)
      Suda K., et al.
    • Journal Title

      Aging and Disease

      Volume: 6 Pages: 438-43

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24890159
  • [Journal Article] Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation.2012

    • Author(s)
      Suda K, et al.
    • Journal Title

      Lung Cancer.

      Volume: 76 Issue: 3 Pages: 292-299

    • DOI

      10.1016/j.lungcan.2011.11.007

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501281, KAKENHI-PROJECT-24890159
  • [Journal Article] Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation--diversity, ductility, and destiny.2012

    • Author(s)
      Suda K., et al.
    • Journal Title

      Cancer and Metastasis Reviews

      Volume: 3-4 Issue: 3-4 Pages: 807-14

    • DOI

      10.1007/s10555-012-9391-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24890159
  • [Presentation] Minimal Residual Disease2023

    • Author(s)
      須田健一, 小原秀太, 宗淳一, 津谷康大, 光冨徹哉
    • Organizer
      第61回日本癌治療学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] Best of WCLC: Early disease: Surgery/Perioperative treatments2023

    • Author(s)
      須田健一
    • Organizer
      第64回日本肺癌学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] 肺がん術後補助療法変革元年における当院での実施状況の変遷2023

    • Author(s)
      須田健一, 小原秀太,  千葉眞人, 下治正樹, 武本智樹,  宗淳一, 津谷康大
    • Organizer
      第66回関西胸部外科学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] 肺がん周術期がん免疫治療の現状とバイオマーカー2023

    • Author(s)
      須田健一、小原秀太、濱田顕、千葉眞人、伊藤正興、下治正樹、武本智樹、宗淳一、光冨徹哉、津谷康大
    • Organizer
      第74回日本気管食道科学会総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] 肺がん外科領域におけるがん免疫療法の進歩と呼吸器外科医の役割2023

    • Author(s)
      須田健一 、濵田顕 、宗淳一 、小原秀太 、千葉眞人 、武本智樹 、光冨徹哉 、津谷康大
    • Organizer
      第123回日本外科学会定期学術集会
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] Discussant: #584 GENETIC PROFILES AND IMMUNE CHECKPOINT EXPRESSION OF PRIMARY OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER AND CORRESPONDING BRAIN METASTASES2023

    • Author(s)
      Kenichi Suda
    • Organizer
      31st ESTS Meeting
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] N0/1 Staging for Limited Resection and Resectable N2 NSCLC2023

    • Author(s)
      Kenichi Suda
    • Organizer
      WCLC 2023
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] PD-L1 高発現 EGFR 変異肺がん外科切除例の検討―術後補助療法の観点から考える―2023

    • Author(s)
      須田健一 、老木華 、福田祥大 、深見朋世 、小原秀太 、濵田顕 、伊藤正興 、千葉眞人 、下治正樹 、武本智樹 、宗淳一 、光冨徹哉 、津谷康大
    • Organizer
      第64回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] EGFR 変異肺がん外科切除例の病態解明と TKI 耐性克服を目指したトランスレーショナル研究2023

    • Author(s)
      須田健一
    • Organizer
      第40回日本呼吸器外科学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] In vitro activity and potential resistance mutations against BI-4020, a 4th generation EGFR-TKI2022

    • Author(s)
      Kenichi Suda, Toshio Fujino, Akira Hamada, Shuta Ohara, Junichi Soh, Tetsuya Mitsudomi
    • Organizer
      2022 World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] 肺がんを知る―飽くなき探求心を引き継いで2022

    • Author(s)
      須田 健一
    • Organizer
      第 63 回日本肺癌学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] 肺がん分子標的治療薬に対する on-target の獲得耐性機序の同定とその克服2022

    • Author(s)
      須田 健一、古賀 教将、西野 将矢、藤野 智大、濵田 顕、下治 正樹、千葉 眞人、武本 智樹、宗 淳一、光冨 徹哉
    • Organizer
      第 122 回日本外科学会定期学術集会
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] Correlation of SUVmax of primary lung tumor and occult lymph node metastases in clinical stage I lung adenocarcinoma2022

    • Author(s)
      Kenichi Suda, Shota Fukuda, Shuta Ohara, Akira Hamada, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Yasuhiro Tsutani, Tetsuya Mitsudomi
    • Organizer
      IASLC 2022 Asia Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K07291
  • [Presentation] TKI耐性2次的変異を同定する手法としてのBa/F3細胞モデルの有用性2021

    • Author(s)
      須田健一,古賀教将,藤野智大,濵田顕,宗淳一,光冨徹哉
    • Organizer
      第115回日本肺癌学会関西支部学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] Inter-tumor heterogeneity of CD44 expression in non-small cell lung cancers / EGFR-mutated lung adenocarcinomas2021

    • Author(s)
      Suda K, Rivard CJ, Yu H, Fujino T, Koga T, Soh J, Hirsch FR, Mitsudomi T.
    • Organizer
      2021 World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] 病理病期 IA2-IIA 期 EGFR 変異肺がんに対するUFT術後補助療法の有用性2021

    • Author(s)
      須田健一、濱田顕、小原秀太、藤野智大、古賀教将、 西野将矢、千葉眞人、下治正樹、武本智樹、宗淳一、光冨徹哉
    • Organizer
      第62回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] EGFR 肺がん外科切除例の特徴と予後 -周術期分子標的治療を視野に入れて2021

    • Author(s)
      須田健一、光冨徹哉
    • Organizer
      第62回日本肺癌学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] 「pN 陽性」非小細胞肺がんにおけるすりガラス成分の有無の予後因子としての意義2021

    • Author(s)
      須田健一、小原秀太、西野将矢、古賀教将、藤野智大、濱田顕、千葉眞人、武本智樹、宗淳一、光冨徹哉
    • Organizer
      第38回日本呼吸器外科学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] EGFR変異肺がんにおけるEGFRチロシンキナーゼ阻害剤耐性克服を目指したトランスレーショナルリサーチ2020

    • Author(s)
      須田健一、光冨徹哉
    • Organizer
      第79回日本癌学会学術総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] In Vitro Validation Study for HER2 Mutations in Squamous Cell Carcinoma as a Potential Predictive Factor Identified in Secondary Analysis of the LUX-Lung 8 Trial2020

    • Author(s)
      Akira Hamada, Kenichi Suda, Toshio Fujino, Masaya Nishino, Takamasa Koga, Shuta Ohara, Masato Chiba, Toshiki Takemoto, Junichi Soh, Tetsuya Mitsudomi
    • Organizer
      2020 World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K09285
  • [Presentation] 第1/2世代 EGFR キナーゼ阻害剤に対する獲得耐性機序の inter-tumor heterogeneity とその臨床的意義2020

    • Author(s)
      須田健一、村上功、小畑慶子、藤野智大、坂井和子、宗淳一、西尾和人、光冨徹哉
    • Organizer
      第79回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] Inter- and intra-tumor heterogeneity of EGFR compound mutations in lung adenocarcinoma2020

    • Author(s)
      Suda K, Sakai K, Obata K, Ohara S, Fujino T, Koga T, Hamada A, Soh J, Nishio K, Mitsudomi T
    • Organizer
      第61回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] In Vitro Validation Study for Afatinib Efficacy in Lung Squamous Cell Carcinoma with HER2 Mutations Identified in LUX-Lung 8 Trial2020

    • Author(s)
      Akira Hamada, Kenichi Suda, Toshio Fujino Shuta Ohara, Junichi Soh, Tetsuya Mitsudomi
    • Organizer
      第79回日本癌学会総会
    • Data Source
      KAKENHI-PROJECT-19K09285
  • [Presentation] 掻把術にて根治できなかった難治性術後膿胸に対するクリスタ ルバイオレットを用いた胸腔内洗浄の有用性2020

    • Author(s)
      須田健一、小原秀太、西野将矢、古賀教将、藤野智大、濱田顕、千葉眞人、武本智樹、 宗淳一、光冨徹哉
    • Organizer
      第37回日本呼吸器外科学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] Pure solid を呈するもPET 陰性であった原発性肺癌の臨床病理学的特徴2020

    • Author(s)
      須田健一、小原秀太、西野将矢、藤野智大、古賀 教将、濱田顕、千葉眞人、武本智樹、宗淳一、光冨徹哉
    • Organizer
      第120回日本外科学会定期学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] Potent in vitro activity of Tarloxotinib for EGFR C797S and other mutations refractory to current EGFR tyrosine kinase inhibitors2019

    • Author(s)
      Suda K, Nishino M, Koga T, Fujino T, Kobayashi Y, Mitsudomi T, Vellanki A, Tirunagaru V.
    • Organizer
      AACR Annual Meeting 2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] pStage IA NSCLCs with ground-glass opacity: are their candidates for Tegafur/Uracil adjuvant chemotherapy?2019

    • Author(s)
      Suda K, Ohara S, Koga T, Fujino T, Hamada A, Nishino M, Chiba M, Takemoto T, Soh J, Mitsudomi T.
    • Organizer
      第60回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.2019

    • Author(s)
      須田健一
    • Organizer
      第119回日本外科学会定期学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] IASLC5: The importance of IASLC Membership for career development opportunities: My personal experience.2019

    • Author(s)
      Suda K.
    • Organizer
      第60回日本肺癌学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] Comparison of PD-L1 expression status between pure-solid versus part-solid tumors in lung adenocarcinomas.2019

    • Author(s)
      Suda K, Shimizu S, Shimoji M, Sato K, Ohara S, Fujino T, Nishino M, Koga T, Hamada A, Tomizawa K, Takemoto T, Soh J, Mitsudomi T.
    • Organizer
      2019 World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] 肺腺がんにおけるPD-L1発現ーすりガラス陰影の有無との関連2019

    • Author(s)
      須田健一、下治正樹、西野将矢、藤野智大、古賀教将、小原秀太、千葉眞人、武本智樹、清水重喜、光冨徹哉
    • Organizer
      第119回日本外科学会定期学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] T790M or C797S confers acquired resistance to tarloxotinib and poziotinibin EGFR exon 20 insertion-driven lung cancer models in vitro.2019

    • Author(s)
      Suda K, Nishino M, Koga T, Fujino T, Ohara S, Soh J, Vellanki A, Tirunagaru V, Mitsudomi T.
    • Organizer
      2019 World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] 自己免疫疾患を有する非小細胞肺癌切除例の短期成績と長期予後2019

    • Author(s)
      須田健一、小原秀太、西野将矢、千葉眞人、武本智樹、宗淳一、光冨徹哉
    • Organizer
      第72回日本胸部外科学会定期学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] 腸型肺腺がんの3切除例2019

    • Author(s)
      須田健一、清水重喜、小原秀太、西野将矢、藤野智大、古賀教将、千葉眞人、下治正樹、武本智樹、光冨徹哉
    • Organizer
      第109回日本肺癌学会関西支部会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] Prediction and prevention of acquired resistance to EGFR-TKIs: a story of HCC4006 cells2018

    • Author(s)
      Kenichi Suda and Tetsuya Mitsudomi
    • Organizer
      第59回日本肺癌学会総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] EGFR-TKI 獲得耐性に伴う上皮間葉転換(EMT)におけるCD44 の役割2018

    • Author(s)
      須田健一、村上功、JihyeKim、Christopher J. Rivard、光冨徹哉、Fred R. Hirsch
    • Organizer
      第118回日本外科学会定期学術集会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] EGFR キナーゼ阻害剤獲得耐性における分子異常の heterogeneity の検討とその克服2018

    • Author(s)
      須田健一
    • Organizer
      第118回日本外科学会定期学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] 早期非小細胞肺がんにおけるPD-L1発現-腫瘍発生部位に着目した検討2018

    • Author(s)
      須田健一、下治正樹、西野将矢、藤野智大、古賀教将、小原秀太、千葉眞人、武本智樹、清水重喜、光冨徹哉
    • Organizer
      第59回日本肺癌学会総会
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] Compound mutations: focusing on EGFR-mutated lung cancers2018

    • Author(s)
      Kenichi Suda
    • Organizer
      77th Annual Meeting of the Japanese Cancer Association
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K07336
  • [Presentation] Qualitative and quantitative heterogeneity in acquiring resistance to EGFR kinase inhibitors in lung cancer2015

    • Author(s)
      Suda K., MUrakami I., Sakai K., et al.
    • Organizer
      WCLC 2015
    • Place of Presentation
      Colorado Convention Center (CO, USA)
    • Year and Date
      2015-09-09
    • Data Source
      KAKENHI-PROJECT-15K18450
  • [Presentation] 要望演題4: 肺腺がんにおける遺伝子異常とその病理形態学的特徴2015

    • Author(s)
      須田健一、 佐藤克明、 清水重喜、 他
    • Organizer
      第32回日本呼吸器外科学会総会
    • Place of Presentation
      サンポートホール高松(香川県)
    • Year and Date
      2015-05-15
    • Data Source
      KAKENHI-PROJECT-15K18450
  • [Presentation] IASLC/ATS/ERS新国際分類に基づく肺腺癌組織亜型における遺伝子変異の探索的検討2015

    • Author(s)
      須田健一、 佐藤克明、 清水重喜、 他
    • Organizer
      第115回日本外科学会定期学術集会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2015-04-18
    • Data Source
      KAKENHI-PROJECT-15K18450
  • [Presentation] EGFR野生型肺癌におけるエルロチニブ獲得耐性機序の探索2014

    • Author(s)
      須田健一、水内寛、佐藤克明、武本智樹、岩崎拓也、南憲司、光冨徹哉
    • Organizer
      第114回日本外科学会定期学術集会
    • Place of Presentation
      京都
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] In vitro analysis of acquired resistance mechanisms to EGFR tyrosine kinase inhibitors in lung cancer2014

    • Author(s)
      Suda K, Mizuuchi H, Sato K, Takemoto T, Iwasaki T, Minami K, Mitsudomi T
    • Organizer
      2nd International Symposium of Training Plan for Oncology Professionals
    • Place of Presentation
      Osaka
    • Invited
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] Several receptor tyrosine kinase is activated but orchestrated by EGFR in EGFR-TKI acquired resistant lung adenocarcinoma cells with EGFR mutation2013

    • Author(s)
      Suda K, Mizuuchi H, Sato K, Takemoto T, Iwasaki T, Minami K, Yatabe Y, Mitsudomi T
    • Organizer
      15th World Conference on Lung Cancer
    • Place of Presentation
      Sydney
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] Prognostic And Predictive Implication Of Epidermal Growth Factor Receptor Gene Mutation On Overall Survival In Non-Small Cell Lung Cancer Patients With Postsurgical Recurrence2013

    • Author(s)
      Suda K.
    • Organizer
      Academic Surgical Congress 2013
    • Place of Presentation
      New Orleans
    • Data Source
      KAKENHI-PROJECT-24890159
  • [Presentation] 臨床検体より樹立したゲフィチニブ獲得耐性細胞株の解析2013

    • Author(s)
      須田健一、伊藤志門、水内寛、武本智樹、岩崎拓也、南憲司、谷田部恭、光冨徹哉
    • Organizer
      第54回日本肺癌学会総会
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] In vitro acquired resistance model to EGFR-TKIs in EGFR mutated lung cancer

    • Author(s)
      Suda K.
    • Organizer
      第71回日本癌学会総会
    • Place of Presentation
      札幌
    • Data Source
      KAKENHI-PROJECT-24890159
  • [Presentation] Molecular and pathological evolution in acquisition of resistance to EGFR-TKI - T790M mutation and SCLC transformation-

    • Author(s)
      Kenichi Suda, Isao Murakami, Katsuaki Sato, Shuta Tomida, Hiroshi Mizuuchi, Kazuko Sakai, Shigeki Shimizu, Kenji Tomizawa, Toshiki Takemoto, Masahiro Sakaguchi, Kazuto Nishio, Yasushi Yatabe, and Tetsuya Mitsudomi
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜(パシフィコ横浜)
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] Reciprocal relationship between EGFR T790M mutation and small cell lung cancer transformation as acquired resistance molecular mechanisms to EGFR kinase inhibitor

    • Author(s)
      Kenichi Suda, Katsuaki Sato, Isao Murakami, Hiroshi Mizuuchi, Kazuko Sakai, Shuta Tomida, Shigeki Shimizu, Yoshihisa Kobayashi, Masaki Shimoji, Kenji Tomizawa, Toshiki Takemoto, Takuya Iwasaki, Masahiro Sakaguchi, Kazuto Nishio, Yasushi Yatabe, and Tetsuya Mitsudomi
    • Organizer
      6th Asia Pacific Lung Cancer Conference
    • Place of Presentation
      Kuala Lumpur(Shangri-La Hotel)
    • Year and Date
      2014-11-06 – 2014-11-08
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] CRKL gene amplification in acquired resistant lung cancers with epidermal growth factor receptor mutation to tyrosine kinase inhibitors - analysis of in vitro models and clinical specimens

    • Author(s)
      Suda K.
    • Organizer
      5th Asia Pacific Lung Cancer Conference
    • Place of Presentation
      Fukuoka
    • Data Source
      KAKENHI-PROJECT-24890159
  • [Presentation] 肺腺癌新国際分類からみたリンパ節転移巣の再評価とその臨床的意義

    • Author(s)
      須田健一、 佐藤克明、 清水重喜、 水内寛、 小林祥久、 下治正樹、 富沢健二、 武本智樹、 岩崎拓也、 阪口全宏、 光冨徹哉
    • Organizer
      第67回日本胸部外科学会定期学術集会
    • Place of Presentation
      福岡(福岡国際会議場、福岡サンパレスホテル&ホール)
    • Year and Date
      2014-09-30 – 2014-10-03
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] 肺腺癌新国際分類によるリンパ節転移巣の再評価とその臨床的意義

    • Author(s)
      須田健一、 佐藤克明、 清水重喜、 水内寛、 小林祥久、 下治正樹、 富沢健二、 武本智樹、 岩崎拓也、 阪口全宏、 光冨徹哉
    • Organizer
      第55回日本肺癌学会学術集会
    • Place of Presentation
      京都(国立京都国際会館)
    • Year and Date
      2014-11-14 – 2014-11-16
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] EGFR野生型肺癌におけるエルロチニブ獲得耐性機序の探索

    • Author(s)
      須田健一、 水内寛、 佐藤克明、 武本智樹、 岩崎拓也、 南憲司、 阪口全宏、 光冨徹哉
    • Organizer
      第114回日本外科学会定期学術集会
    • Place of Presentation
      京都(国立京都国際会館、グランドプリンスホテル京都)
    • Year and Date
      2014-04-03 – 2014-04-05
    • Data Source
      KAKENHI-PROJECT-25830119
  • [Presentation] 肺癌術後再発患者におけるEGFR遺伝子変異の全生存における意義 -予後因子と予測因子-

    • Author(s)
      須田 健一
    • Organizer
      第50回日本癌治療学会総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-24890159
  • 1.  Soh Junichi (90559890)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 2 results
  • 2.  光冨 徹哉 (70209807)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 3.  津谷 康大 (10534985)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 4.  小原 秀太 (20813926)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 5.  冨田 秀太 (10372111)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 6.  豊岡 伸一 (30397880)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  山本 寛斉 (40467733)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  阪口 政清 (70379840)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  諏澤 憲 (90839713)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 10.  坂井 和子 (20580559)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 11.  西尾 和人 (10208134)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 12.  濱田 顕 (80772954)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 13.  MIZUUCHI Hiroshi
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 12 results
  • 14.  SATO Katsuaki
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 12 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi